US 11,987,694 B2
Flowable bulk granular polysaccharide
Timothy Allan Bell, Wilmington, DE (US); Dean M. Fake, Wilmington, DE (US); Scott M. Herkimer, Wilmington, DE (US); Dhiren V. Patel, Hockessin, DE (US); and Tyler D. Pritchett, Bear, DE (US)
Assigned to NUTRITION & BIOSCIENCES USA 4, INC., Rochester, NY (US)
Filed by Nutrition & Biosciences USA 4, Inc., Rochester, NY (US)
Filed on Mar. 1, 2021, as Appl. No. 17/187,968.
Application 17/187,968 is a continuation of application No. 16/774,040, filed on Jan. 28, 2020, granted, now 10,934,418.
Application 16/774,040 is a continuation of application No. 16/158,327, filed on Oct. 12, 2018, granted, now 10,584,233.
Claims priority of provisional application 62/725,532, filed on Aug. 31, 2018.
Claims priority of provisional application 62/571,995, filed on Oct. 13, 2017.
Prior Publication US 2021/0355299 A1, Nov. 18, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. C08L 5/00 (2006.01); C08B 37/00 (2006.01); C12P 19/04 (2006.01); C12P 19/18 (2006.01)
CPC C08L 5/00 (2013.01) [C08B 37/0009 (2013.01); C12P 19/04 (2013.01); C12P 19/18 (2013.01)] 20 Claims
 
1. Particles with an average size of about 0.1-10 mm, wherein said particles comprise at least
(i) about 50%-90% by weight water or an aqueous solution, and
(ii) about 10%-50% by weight insoluble alpha-glucan or an insoluble cationic ether of said insoluble alpha-glucan, wherein the insoluble alpha-glucan comprises a graft copolymer having
(a) a backbone comprising dextran with a molecular weight of at least about 100000 Daltons, and
(b) alpha-glucan side chains comprising at least about 95% alpha-1,3-glycosidic linkages.